VAG
AGN

VisionPoint Advisory Group’s Allergan plc AGN Stock Holding History

VisionPoint Advisory Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,103
Closed -$550K – 142
2020
Q1 		$550K Buy
+3,103
New +$584K 0.26% 55

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

VisionPoint Advisory Group's AGN Position: Q2 2020 in Review

VisionPoint Advisory Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,103 shares — an estimated $550K sold.

VisionPoint Advisory Group first reported a position in AGN in Q1 2020 and held it in 1 quarter. The position peaked at $550K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • VisionPoint Advisory Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • VisionPoint Advisory Group sold 3,103 Allergan plc shares in Q2 2020, an estimated $550K.
  • VisionPoint Advisory Group first reported a position in Allergan plc in Q1 2020 and held it in 1 quarter.
  • VisionPoint Advisory Group's Allergan plc position peaked at $550K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on VisionPoint Advisory Group's 13F filing for Q2 2020, filed 14 Aug 2020.